Treatment of Ringworm (Tinea) Infections
For ringworm infections, treatment depends critically on the location and causative organism: use topical antifungals (azoles or terbinafine) for localized skin infections (tinea corporis, cruris, pedis), but oral systemic therapy is mandatory for scalp infections (tinea capitis) and nail infections (onychomycosis). 1
Location-Based Treatment Algorithm
Tinea Corporis, Cruris, and Pedis (Body, Groin, Feet)
Topical therapy alone is sufficient for most cases:
- Apply topical azoles (clotrimazole, miconazole) or allylamines (terbinafine) for 2 weeks (corporis/cruris) or 4 weeks (pedis)
- Continue treatment for at least 1 week after clinical clearing 2
- Allylamines require shorter duration (1-2 weeks) compared to azoles 2
Escalate to oral therapy if:
- Extensive disease coverage
- Failure of topical treatment
- Immunocompromised patient
- Hair follicle involvement 3
Tinea Capitis (Scalp)
Oral systemic therapy is absolutely required—topical therapy alone will fail. 1
The choice of oral agent depends on the causative organism:
For Trichophyton species (T. tonsurans, T. violaceum, T. soudanense):
- First-line: Terbinafine 1
- <20 kg: 62.5 mg daily for 2-4 weeks
- 20-40 kg: 125 mg daily for 2-4 weeks
40 kg: 250 mg daily for 2-4 weeks
For Microsporum species (M. canis, M. audouinii):
- First-line: Griseofulvin 1
- <50 kg: 15-20 mg/kg/day for 6-8 weeks
50 kg: 1 g/day for 6-8 weeks
- Take with fatty food to enhance absorption 1
Critical point: Terbinafine is highly effective against Trichophyton but relatively ineffective against Microsporum because it cannot reach adequate concentrations in prepubertal children's hair shafts and scalp surface where Microsporum spores reside. 1
Treatment Failure Management
If no clinical improvement occurs:
- First, assess: compliance, drug absorption, possible reinfection
- If culture-positive but clinically improving: continue current therapy 2-4 more weeks
- If no initial improvement: switch to second-line therapy 1
Second-line options:
- Itraconazole: 50-100 mg/day or 5 mg/kg/day for 2-4 weeks (effective against both Trichophyton and Microsporum) 1
- Fluconazole: Alternative option, though more limited by side effects and cost 1
Emerging Resistant Infections
Critical warning: Trichophyton indotineae (formerly T. mentagrophytes genotype VIII) is spreading globally with terbinafine resistance. 4, 5
Suspect T. indotineae if:
- Extensive or unusually severe presentation
- Terbinafine treatment failure
- History of travel to endemic regions (particularly South Asia)
- Atypical presentation mimicking eczema or psoriasis 4, 5
For confirmed T. indotineae:
- Oral itraconazole 100-200 mg/day for 6-8 weeks (or longer as needed) 5
- Add topical luliconazole 1% cream as adjunctive therapy 5
- If itraconazole fails: oral posaconazole 300 mg/day for 4-12 weeks 5
Important Caveats and Pitfalls
Avoid combination antifungal-corticosteroid products except in very limited circumstances:
- May only be used in healthy adults with heavily inflamed tinea corporis, cruris, or pedis
- Never use in children <12 years
- Never use on face or occluded areas (including diaper region)
- Maximum duration: 2 weeks for cruris, 4 weeks for pedis/corporis
- Switch to pure antifungal once symptoms improve 6
- Corticosteroids can suppress local immunity, allow deeper fungal invasion, and mask persistent infection 6
For tinea capitis specifically:
- Endpoint is mycological cure, not just clinical improvement—repeat cultures until clearance confirmed 1
- Children on appropriate therapy can attend school/nursery 1
- Screen and treat all family members for T. tonsurans cases (>50% may be infected) 1
- Add antifungal shampoo (ketoconazole 2%, selenium sulfide 1%, or povidone-iodine) to reduce spore transmission 1
Diagnostic confirmation is essential: